Tricuspid Valve Replacement in Children

Pasque, Michael K.; Williams, William G.; Coles, John G.; Trusler, George A.; Freedom, Robert M.

doi:10.1016/s0003-4975(10)62032-2

Cited by 33 publications

(12 citation statements)

References 26 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…When the leftside valve dysfunction is fi xed, tricuspid valve regurgitation often resolves and sometimes disappears. Functional tricuspid valve regurgitation has been shown to recover in 47% of patients because of postoperative pulmonary resistance [Pasque 1987]. In addition, postoperative functional capacity, which is related to inadequate repair or negligence of the tricuspid valve, is based on the results of mitral valve surgery [Pasque 1987].…”

Section: Discussionmentioning

confidence: 99%

“…Functional tricuspid valve regurgitation has been shown to recover in 47% of patients because of postoperative pulmonary resistance [Pasque 1987]. In addition, postoperative functional capacity, which is related to inadequate repair or negligence of the tricuspid valve, is based on the results of mitral valve surgery [Pasque 1987]. Because the tricuspid valve is functioning in a low-pressure system, inaccurate results can be tolerated.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Outcomes of De Vega versus Biodegradable Ring Annuloplasty in the Surgical Treatment of Tricuspid Regurgitation (Mid-term Results)

Başel¹,

Ünal²,

Kutlu³

et al. 2010

The Heart Surgery Forum

View full text Add to dashboard Cite

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

Outcomes of De Vega versus Biodegradable Ring Annuloplasty in the Surgical Treatment of Tricuspid Regurgitation (Mid-term Results)

Başel¹,

Ünal²,

Kutlu³

et al. 2010

The Heart Surgery Forum

View full text Add to dashboard Cite

show abstract

“…The surgical literature is replete with reports regarding the fate of mechanical prostheses implanted in the tricuspid position.l-1° However, there is little information available regarding early and late phase events following bioprosthetic valve implantation in the tricuspid position. [11][12][13][14][15] The purpose of this review was to retrospectively analyze events in a consecutive series of patients having tricuspid valve replacement utilizing a bioprosthetic valve.…”

mentioning

confidence: 99%

Early and Late Phase Events Following Bioprosthetic Tricuspid Valve Replacement

et al. 1992

View full text Add to dashboard Cite

From 1961 through 1987, 9,247 patients underwent an intracardiac repair for valvular heart disease. Five hundred thirty patients had a procedure that included a tricuspid valve operation (6%), with tricuspid valve replacement performed in 175 patients (2%), of whom 154 had a bioprosthetic valve implanted (1.7%). These 154 patients with a bioprosthetic valve in the tricuspid position are the subject of this review. There were 27 males and 127 females. Ages ranged from 10 to 75 years. There was tricuspid valve insufficiency in 139 patients (90%), and stenosis plus insufficiency in 15 (10%). Carpentier-Edwards prostheses were implanted in 83 (54%), Ionescu-Shiley in 55 (35%), Hancock in 12 (8%), and Mitroflow in 4 (3%). Concomitant procedures were performed in 146 patients (95%). At least one previous operation had been performed in 86 patients (56%). Preoperatively, 139 patients were in functional Class III or IV (90%). Hospital death occurred in 20 patients (13%). Logistic regression analysis revealed that incremental risk factors for hospital death included increasing peripheral edema preoperatively (p = 0.04), and use of a Hancock prosthesis in the tricuspid position (p = 0.03). All 134 hospital survivors were followed at a mean of 66.01 months, range 1 to 162 months. There were 70 late deaths (52%). Log-rank test indicated that incremental risk factors for late death were: longer cross-clamp time at repair (p = 0.0007); higher pulmonary artery systolic pressure preoperatively (p = 0.01); earlier date of surgery (p = 0.03); and larger tricuspid prosthesis size (p = 0.06).(ABSTRACT TRUNCATED AT 250 WORDS)

show abstract

“…Surgical correction of Ebstein's disease by a prosthetic valve replacement was first reported in 1963 and has yielded poor results; several modifications of valve repair techniques were introduced to create a monocusp valve and commissuroplasty or annuloplasty to restore competence of the tricuspid valve. 2,11,12,13 Danielson et al performed horizontal plication of the "atrialized" portion of the right ventricle, and right atrial reduction, while Chauvaud and Quaegebeur performed longitudinal plication for restoring the geometry and compliance of the right ventricle in addition to valvuloplasty. 3,14 The important component of repair in Ebstein's disease is a creation of a monocusp valve, generally with a large anterior tricuspid leaflet either by a single or multiple stitch technique, commissuroplasty, with or without plication of the "atrialized" right ventricle.…”

Section: Resultsmentioning

confidence: 99%